Clinical Trials Directory

Trials / Unknown

UnknownNCT03087383

Identification of Genetic Polymorphisms Related to Propofol Requirement and Recovery Through Genome-wide Association Study (GWAS) in Total Intravenous Anesthesia for Clipping of Unruptured Cerebral Aneurysm in Korean Population

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

In neurosurgical anesthesia, propofol based total intravenous anesthesia (TIVA) is frequently used due to brain relaxation and less effect on electrophysiologic monitoring. Response to propofol can vary between individuals and be associated with clinical factors including age and weight, and genetic polymorphism. Because the importance of rapid recovery in neurosurgery with long operation time is emphasized recently, the choice and dose adjustment of anesthetics should be determined according to clinical and genetic factors. Recently, researches about genetic variations have been performed with single nucleotide polymorphism (SNP). The aim of this study is to find SNPs associated with propofol recovery and response through genome-wide association study (GWAS) in Korean adult population undergoing propofol based TIVA for clipping of unruptured cerebral aneurysm.

Conditions

Timeline

Start date
2017-03-02
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2017-03-22
Last updated
2019-03-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03087383. Inclusion in this directory is not an endorsement.